|
Name |
(13E,19E)-10-Phenyl-16alpha,18beta-dimethyl-18-hydroxy-21beta-acetoxy-6,7beta-epoxy[11]cytochalasa-13,19-diene-1,17-dione
|
Molecular Formula | C30H37NO6 | |
IUPAC Name* |
[(1R,2R,3E,5R,7S,9E,11R,12S,14R,15S,16R,17S)-17-benzyl-5-hydroxy-5,7,14,15-tetramethyl-6,19-dioxo-13-oxa-18-azatetracyclo[9.8.0.01,16.012,14]nonadeca-3,9-dien-2-yl] acetate
|
|
SMILES |
C[C@H]1C/C=C/[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2([C@@H](/C=C/[C@@](C1=O)(C)O)OC(=O)C)C(=O)N[C@H]4CC5=CC=CC=C5)C)C
|
|
InChI |
InChI=1S/C30H37NO6/c1-17-10-9-13-21-26-29(5,37-26)18(2)24-22(16-20-11-7-6-8-12-20)31-27(34)30(21,24)23(36-19(3)32)14-15-28(4,35)25(17)33/h6-9,11-15,17-18,21-24,26,35H,10,16H2,1-5H3,(H,31,34)/b13-9+,15-14+/t17-,18-,21-,22-,23+,24-,26-,28+,29+,30+/m0/s1
|
|
InChIKey |
XHEQULXTQLICFN-QDNKZWAGSA-N
|
|
Synonyms |
MLS005941363; CHEMBL299905; SMR004614077; (13E,19E)-10-Phenyl-16alpha,18beta-dimethyl-18-hydroxy-21beta-acetoxy-6,7beta-epoxy[11]cytochalasa-13,19-diene-1,17-dione; (7S,12S,15S,17S,1R,2R,5R,11R,14R)-18-Aza-5-hydroxy-5,7,14,15-tetramethyl-13-oxa-6,19-dioxo-17-benzyltetracyclo[9.8.0.0<1,16>.0<12,14>]nonadeca-3,9-dien-2-yl acetate
|
|
CAS | NA | |
PubChem CID | 11970174 | |
ChEMBL ID | CHEMBL299905 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 507.6 | ALogp: | 3.3 |
HBD: | 2 | HBA: | 6 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 105.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 37 | QED Weighted: | 0.365 |
Caco-2 Permeability: | -5.039 | MDCK Permeability: | 0.00001280 |
Pgp-inhibitor: | 0.969 | Pgp-substrate: | 0.284 |
Human Intestinal Absorption (HIA): | 0.192 | 20% Bioavailability (F20%): | 0.56 |
30% Bioavailability (F30%): | 0.039 |
Blood-Brain-Barrier Penetration (BBB): | 0.219 | Plasma Protein Binding (PPB): | 80.86% |
Volume Distribution (VD): | 0.744 | Fu: | 5.83% |
CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.112 |
CYP2C19-inhibitor: | 0.158 | CYP2C19-substrate: | 0.536 |
CYP2C9-inhibitor: | 0.228 | CYP2C9-substrate: | 0.049 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.102 |
CYP3A4-inhibitor: | 0.925 | CYP3A4-substrate: | 0.501 |
Clearance (CL): | 2.589 | Half-life (T1/2): | 0.545 |
hERG Blockers: | 0.084 | Human Hepatotoxicity (H-HT): | 0.679 |
Drug-inuced Liver Injury (DILI): | 0.941 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.886 | Maximum Recommended Daily Dose: | 0.975 |
Skin Sensitization: | 0.099 | Carcinogencity: | 0.026 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.854 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002762 | 0.820 | D06CWH | 0.272 | ||||
ENC002828 | 0.804 | D0V3ZA | 0.271 | ||||
ENC004026 | 0.765 | D0W7RJ | 0.268 | ||||
ENC001886 | 0.754 | D01TSI | 0.264 | ||||
ENC004444 | 0.733 | D09NNH | 0.264 | ||||
ENC004463 | 0.706 | D0SP3D | 0.263 | ||||
ENC005442 | 0.700 | D0R1BD | 0.260 | ||||
ENC001756 | 0.683 | D07HOF | 0.250 | ||||
ENC003712 | 0.680 | D00OAY | 0.248 | ||||
ENC003653 | 0.678 | D0K5OT | 0.248 |